hai lan chen
Old Dominion University
Norfolk, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Old Dominion University
Norfolk, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Rutgers, The State University of New Jersey
New Brunswick, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
College of Medicine, National Cheng Kung University
Tainan, Taiwan
Associate Editor
Cancer Molecular Targets and Therapeutics
Engelhardt Institute of Molecular Biology (RAS)
Moscow, Russia
Associate Editor
Cancer Molecular Targets and Therapeutics
Clark Atlanta University
Atlanta, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Rome Tor Vergata
Roma, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Florence
Florence, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Otago, Christchurch
Christchurch, New Zealand
Associate Editor
Cancer Molecular Targets and Therapeutics
Agostino Gemelli University Polyclinic (IRCCS)
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Toledo Medical Center
Toledo, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Catholic University of the Sacred Heart
Milano, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Brown University
Providence, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Cancer Molecular Targets and Therapeutics
UNICAMILLUS, INTERNATIONAL UNIVERSITY OF HEALTH SCIENCES
Rome, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
Medical University of South Carolina
Charleston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics